Cargando…

Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review

OBJECTIVE: To systematically review evidence on effectiveness of contact tracing apps (CTAs) for SARS-CoV-2 on epidemiological and clinical outcomes. DESIGN: Rapid systematic review. DATA SOURCES: EMBASE (OVID), MEDLINE (PubMed), BioRxiv and MedRxiv were searched up to 28 October 2020. STUDY SELECTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenniskens, Kevin, Bootsma, Martin C J, Damen, Johanna A A G, Oerbekke, Michiel S, Vernooij, Robin W M, Spijker, René, Moons, Karel G M, Kretzschmar, Mirjam E E, Hooft, Lotty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277487/
https://www.ncbi.nlm.nih.gov/pubmed/34253676
http://dx.doi.org/10.1136/bmjopen-2021-050519
_version_ 1783722083444850688
author Jenniskens, Kevin
Bootsma, Martin C J
Damen, Johanna A A G
Oerbekke, Michiel S
Vernooij, Robin W M
Spijker, René
Moons, Karel G M
Kretzschmar, Mirjam E E
Hooft, Lotty
author_facet Jenniskens, Kevin
Bootsma, Martin C J
Damen, Johanna A A G
Oerbekke, Michiel S
Vernooij, Robin W M
Spijker, René
Moons, Karel G M
Kretzschmar, Mirjam E E
Hooft, Lotty
author_sort Jenniskens, Kevin
collection PubMed
description OBJECTIVE: To systematically review evidence on effectiveness of contact tracing apps (CTAs) for SARS-CoV-2 on epidemiological and clinical outcomes. DESIGN: Rapid systematic review. DATA SOURCES: EMBASE (OVID), MEDLINE (PubMed), BioRxiv and MedRxiv were searched up to 28 October 2020. STUDY SELECTION: Studies, both empirical and model-based, assessing effect of CTAs for SARS-CoV-2 on reproduction number (R), total number of infections, hospitalisation rate, mortality rate, and other epidemiologically and clinically relevant outcomes, were eligible for inclusion. DATA EXTRACTION: Empirical and model-based studies were critically appraised using separate checklists. Data on type of study (ie, empirical or model-based), sample size, (simulated) time horizon, study population, CTA type (and associated interventions), comparator and outcomes assessed, were extracted. The most important findings were extracted and narratively summarised. Specifically for model-based studies, characteristics and values of important model parameters were collected. RESULTS: 2140 studies were identified, of which 17 studies (2 empirical, 15 model-based studies) were eligible and included in this review. Both empirical studies were observational (non-randomised) studies and at high risk of bias, most importantly due to risk of confounding. Risk of bias of model-based studies was considered low for 12 out of 15 studies. Most studies demonstrated beneficial effects of CTAs on R, total number of infections and mortality rate. No studies assessed effect on hospitalisation. Effect size was dependent on model parameters values used, but in general, a beneficial effect was observed at CTA adoption rates of 20% or higher. CONCLUSIONS: CTAs have the potential to be effective in reducing SARS-CoV-2 related epidemiological and clinical outcomes, though effect size depends on other model parameters (eg, proportion of asymptomatic individuals, or testing delays), and interventions after CTA notification. Methodologically sound comparative empirical studies on effectiveness of CTAs are required to confirm findings from model-based studies.
format Online
Article
Text
id pubmed-8277487
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82774872021-07-15 Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review Jenniskens, Kevin Bootsma, Martin C J Damen, Johanna A A G Oerbekke, Michiel S Vernooij, Robin W M Spijker, René Moons, Karel G M Kretzschmar, Mirjam E E Hooft, Lotty BMJ Open Epidemiology OBJECTIVE: To systematically review evidence on effectiveness of contact tracing apps (CTAs) for SARS-CoV-2 on epidemiological and clinical outcomes. DESIGN: Rapid systematic review. DATA SOURCES: EMBASE (OVID), MEDLINE (PubMed), BioRxiv and MedRxiv were searched up to 28 October 2020. STUDY SELECTION: Studies, both empirical and model-based, assessing effect of CTAs for SARS-CoV-2 on reproduction number (R), total number of infections, hospitalisation rate, mortality rate, and other epidemiologically and clinically relevant outcomes, were eligible for inclusion. DATA EXTRACTION: Empirical and model-based studies were critically appraised using separate checklists. Data on type of study (ie, empirical or model-based), sample size, (simulated) time horizon, study population, CTA type (and associated interventions), comparator and outcomes assessed, were extracted. The most important findings were extracted and narratively summarised. Specifically for model-based studies, characteristics and values of important model parameters were collected. RESULTS: 2140 studies were identified, of which 17 studies (2 empirical, 15 model-based studies) were eligible and included in this review. Both empirical studies were observational (non-randomised) studies and at high risk of bias, most importantly due to risk of confounding. Risk of bias of model-based studies was considered low for 12 out of 15 studies. Most studies demonstrated beneficial effects of CTAs on R, total number of infections and mortality rate. No studies assessed effect on hospitalisation. Effect size was dependent on model parameters values used, but in general, a beneficial effect was observed at CTA adoption rates of 20% or higher. CONCLUSIONS: CTAs have the potential to be effective in reducing SARS-CoV-2 related epidemiological and clinical outcomes, though effect size depends on other model parameters (eg, proportion of asymptomatic individuals, or testing delays), and interventions after CTA notification. Methodologically sound comparative empirical studies on effectiveness of CTAs are required to confirm findings from model-based studies. BMJ Publishing Group 2021-07-12 /pmc/articles/PMC8277487/ /pubmed/34253676 http://dx.doi.org/10.1136/bmjopen-2021-050519 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Jenniskens, Kevin
Bootsma, Martin C J
Damen, Johanna A A G
Oerbekke, Michiel S
Vernooij, Robin W M
Spijker, René
Moons, Karel G M
Kretzschmar, Mirjam E E
Hooft, Lotty
Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review
title Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review
title_full Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review
title_fullStr Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review
title_full_unstemmed Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review
title_short Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review
title_sort effectiveness of contact tracing apps for sars-cov-2: a rapid systematic review
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277487/
https://www.ncbi.nlm.nih.gov/pubmed/34253676
http://dx.doi.org/10.1136/bmjopen-2021-050519
work_keys_str_mv AT jenniskenskevin effectivenessofcontacttracingappsforsarscov2arapidsystematicreview
AT bootsmamartincj effectivenessofcontacttracingappsforsarscov2arapidsystematicreview
AT damenjohannaaag effectivenessofcontacttracingappsforsarscov2arapidsystematicreview
AT oerbekkemichiels effectivenessofcontacttracingappsforsarscov2arapidsystematicreview
AT vernooijrobinwm effectivenessofcontacttracingappsforsarscov2arapidsystematicreview
AT spijkerrene effectivenessofcontacttracingappsforsarscov2arapidsystematicreview
AT moonskarelgm effectivenessofcontacttracingappsforsarscov2arapidsystematicreview
AT kretzschmarmirjamee effectivenessofcontacttracingappsforsarscov2arapidsystematicreview
AT hooftlotty effectivenessofcontacttracingappsforsarscov2arapidsystematicreview